49
Growth Score in past quarter
pts
Heat Score 49 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
783645
NewBio develops a new generation of drugs to overcome the limitations of current treatments and transform the lives of patients.
David C Yeomans: Founder
About the Company
NewBio develops a new generation of drugs to overcome the limitations of current treatments and transform the lives of patients. NewBio discovered new biology that allows focusing on many targets within the cancer gene regulatory network with a single hyperOligo drug, seeing the forest instead of the trees.
It was founded in 2021 by David Yeomans
and is located in San Francisco Bay Area.